World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
18884
World Ranking
2951
National Ranking
1174

Overview

Patrizia Farci is affiliated with the National Institutes of Health in the United States and specializes in medical research with a focus on hepatology, epidemiology, infectious diseases, molecular biology, and oncology. Their work primarily revolves around liver diseases and viral hepatitis.

Farci's frequent co-authors include Ronald E. Engle, Hanh Nguyen, Harvey J. Alter, Zhaochun Chen, and Fausto Zamboni. These collaborations have contributed to a range of research efforts in liver-related viral infections and associated clinical outcomes.

The scientist has contributed extensively to various academic journals. Notable publication venues include:

  • PLoS Pathogens (3 publications)
  • Proceedings of the National Academy of Sciences (2 publications)
  • Journal of Viral Hepatitis (2 publications)
  • Journal of Hepatology (1 publication)
  • Nature Reviews Gastroenterology & Hepatology (1 publication)

Farci's research covers a variety of topics with significant emphasis on hepatitis viruses and liver conditions. Main topics addressed in their publications include:

  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis Viruses Studies and Epidemiology
  • Liver Disease and Transplantation
  • Viral Gastroenteritis Research and Epidemiology
  • COVID-19 Clinical Research Studies

Recent publications by Farci include the following papers:

  • "EASL Clinical Practice Guidelines on hepatitis delta virus," 2023, Journal of Hepatology
  • "A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook," 2022, Nature Reviews Gastroenterology & Hepatology
  • "Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis," 2021, Proceedings of the National Academy of Sciences
  • "Hepatitis D Virus and Hepatocellular Carcinoma," 2021, Viruses
  • "Endpoints and New Options for Treatment of Chronic Hepatitis D," 2021, Hepatology

Best Publications

  • Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

    Patrick Marcellin;George K.K. Lau;Ferruccio Bonino;Patrizia Farci

  • The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

    Patrizia Farci;Atsushi Shimoda;Alessandra Coiana;Giacomo Diaz

  • Lack of protective immunity against reinfection with hepatitis C virus

    Patrizia Farci;Harvey J. Alter;Sugantha Govindarajan;Doris C. Wong

  • Prevention of Hepatitis C Virus Infection in Chimpanzees by Hyperimmune Serum against the Hypervariable Region 1 of the Envelope 2 Protein

    Patrizia Farci;Atsushi Shimoda;Doris Wong;Teresa Cabezon

  • A Long-Term Study of Hepatitis C Virus Replication in Non-A, Non-B Hepatitis

    Patrizia Farci;Harvey J. Alter;Doris Wong;Roger H. Miller

  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362].

    Patrizia Farci

  • Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

    Maurizia Rossana Brunetto;Francesco Moriconi;Ferruccio Bonino;George K. K. Lau

  • Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

    Patrizia Farci;Harvey J. Alter;Doris C. Wong;Roger H. Miller

  • INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B

    Antonina Smedile;Giorgio Verme;Antonietta Cargnel;Pietro Dentico

  • Chronic Hepatitis in Carriers of Hepatitis B Surface Antigen, with Intrahepatic Expression of the Delta Antigen: An Active and Progressive Disease Unresponsive to Immunosuppressive Treatment

    Mario Rizzetto;Giorgio Verme;Serafino Recchia;Ferruccio Bonino

  • Serological response to the hepatitis dSerological response to the hepatitis delta virus in hepatitis D.

    M Aragona;S Macagno;F Caredda;O Crivelli

  • Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

    Patrick Marcellin;Ferruccio Bonino;George K.K. Lau;Patrizia Farci

  • Treatment of Chronic Hepatitis D with Interferon Alfa-2a

    Farci P;Mandas A;Coiana A;Lai Me

  • Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

    P. Lusso;F. Cocchi;C. Balotta;P. D. Markham

  • Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

    M.E. Lai;A.P. Mazzoleni;A. Balestrieri;F. Argiolu

  • Long-term benefit of interferon α therapy of chronic hepatitis D: regression of advanced hepatic fibrosis

    Patrizia Farci;Tania Roskams;Luchino Chessa;Giovanna Peddis

  • Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.

    Ferruccio Bonino;P Marcellin;Gk Lau;S Hadziyannis

  • Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.

    Stefan Zeuzem;Moisés Diago;Edward Gane;K. Rajender Reddy

  • Delta hepatitis: an update

    Patrizia Farci

  • Clinical significance of hepatitis C virus genotypes and quasispecies.

    P Farci;R H Purcell

  • Serological response to the hepatitis delta virus in hepatitis D.

    M. Aragona;F. Caredda;C. Lavarini;P. Farci

Frequent Co-Authors

Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Ronald E. Engle
Ronald E. Engle National Institute of Allergy and Infectious Diseases
Harvey J. Alter
Harvey J. Alter National Institutes of Health
Sugantha Govindarajan
Sugantha Govindarajan University of Southern California
Ferruccio Bonino
Ferruccio Bonino National Research Council (CNR)
David E. Kleiner
David E. Kleiner National Institutes of Health
Xiaoping Su
Xiaoping Su The University of Texas MD Anderson Cancer Center
Jens Bukh
Jens Bukh University of Copenhagen
Mario Rizzetto
Mario Rizzetto University of Turin
Xifeng Wu
Xifeng Wu Zhejiang University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related fields like health information management can open diverse career opportunities. Pursuing a master in health information management salary often reflects the growing demand for professionals who can bridge healthcare and data management. This degree offers competitive salaries and dynamic career paths in healthcare administration.

When selecting programs, accreditation matters. The best online health information management degree cahiim accredited options ensure that your education meets industry standards, preparing you effectively for certification and employment in this growing field.

For those seeking faster entry into the healthcare sector, certificate programs like the best fastest online medical billing and coding certificate programs provide practical skills that are in high demand. These programs complement microbiology knowledge by facilitating administrative roles within medical facilities.

Moreover, healthcare education continues to evolve, with many flexible options available. Interested learners can explore what medical degrees can i get online to find accredited programs that fit their schedules while advancing their medical and scientific expertise.

Best Scientists Citing Patrizia Farci

Trending Scientists

Recently Published Articles